1. Home
  2. DUOT vs IPSC Comparison

DUOT vs IPSC Comparison

Compare DUOT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • IPSC
  • Stock Information
  • Founded
  • DUOT 1990
  • IPSC 2019
  • Country
  • DUOT United States
  • IPSC United States
  • Employees
  • DUOT N/A
  • IPSC N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • DUOT Technology
  • IPSC Health Care
  • Exchange
  • DUOT Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • DUOT 66.3M
  • IPSC 62.1M
  • IPO Year
  • DUOT N/A
  • IPSC 2021
  • Fundamental
  • Price
  • DUOT $6.83
  • IPSC $0.73
  • Analyst Decision
  • DUOT Strong Buy
  • IPSC Strong Buy
  • Analyst Count
  • DUOT 2
  • IPSC 5
  • Target Price
  • DUOT $10.75
  • IPSC $11.00
  • AVG Volume (30 Days)
  • DUOT 151.3K
  • IPSC 493.4K
  • Earning Date
  • DUOT 03-31-2025
  • IPSC 03-13-2025
  • Dividend Yield
  • DUOT N/A
  • IPSC N/A
  • EPS Growth
  • DUOT N/A
  • IPSC N/A
  • EPS
  • DUOT N/A
  • IPSC N/A
  • Revenue
  • DUOT $7,346,014.00
  • IPSC $2,684,000.00
  • Revenue This Year
  • DUOT $16.88
  • IPSC $230.60
  • Revenue Next Year
  • DUOT $183.85
  • IPSC $31.83
  • P/E Ratio
  • DUOT N/A
  • IPSC N/A
  • Revenue Growth
  • DUOT N/A
  • IPSC 7.88
  • 52 Week Low
  • DUOT $2.03
  • IPSC $0.68
  • 52 Week High
  • DUOT $8.53
  • IPSC $5.51
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 52.05
  • IPSC 30.98
  • Support Level
  • DUOT $6.30
  • IPSC $0.72
  • Resistance Level
  • DUOT $7.63
  • IPSC $0.82
  • Average True Range (ATR)
  • DUOT 0.82
  • IPSC 0.06
  • MACD
  • DUOT -0.06
  • IPSC 0.01
  • Stochastic Oscillator
  • DUOT 57.51
  • IPSC 27.43

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: